Director William Stromberg buys GE HealthCare (GEHC) stock

Rhea-AI Filing Summary

GE HealthCare Technologies Inc. director William J. Stromberg reported an open-market purchase of company stock. On May 6, 2026, he bought 1,000 shares of common stock at $61.6892 per share, bringing his directly held ownership to 15,330 shares after the transaction.

Insider Trade Summary

Net Buyer: 1,000 shares ($61,689)

Net Buy 1 txn

Insider Stromberg William J

Role null

Bought 1,000 shs ($62K)

Type	Security	Shares	Price	Value
Purchase	Common Stock, par value $0.01 per share	1,000	$61.6892	$62K

Holdings After Transaction: Common Stock, par value $0.01 per share — 15,330 shares (Direct, null)

Footnotes (1)

Key Figures

Shares purchased: 1,000 shares Purchase price: $61.6892 per share Shares owned after transaction: 15,330 shares

3 metrics

Shares purchased 1,000 shares Open-market buy on May 6, 2026

Purchase price $61.6892 per share Common stock transaction

Shares owned after transaction 15,330 shares Direct ownership following Form 4 trade

Key Terms

open-market purchase, Form 4, beneficial ownership

3 terms

open-market purchase financial

"transaction_action: "open-market purchase""

An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.

Form 4 regulatory

"INSIDER FILING DATA (Form 4):"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

beneficial ownership financial

"total_shares_following_transaction shows beneficial ownership after trade"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Stromberg William J

(Last) (First) (Middle)

500 W. MONROE STREET

(Street)

CHICAGO ILLINOIS 60661

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
GE HealthCare Technologies Inc. [ GEHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/06/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $0.01 per share	05/06/2026		P		1,000	A	$61.6892	15,330	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	/s/ Frank R. Jimenez, General Counsel and Corporate Secretary, as attorney-in-fact	05/07/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did GEHC director William J. Stromberg report?

Director William J. Stromberg reported an open-market purchase of GE HealthCare Technologies Inc. stock. On May 6, 2026, he bought 1,000 shares of common stock at $61.6892 per share, increasing his directly held position to 15,330 shares after the transaction.

How many GEHC shares did William J. Stromberg buy and at what price?

William J. Stromberg bought 1,000 GE HealthCare Technologies Inc. shares in an open-market transaction. The reported purchase price was $61.6892 per share, as disclosed in the Form 4 insider filing for the non-derivative common stock transaction dated May 6, 2026.

What is William J. Stromberg’s GEHC shareholding after this Form 4 transaction?

After the reported purchase, William J. Stromberg directly holds 15,330 GE HealthCare Technologies Inc. shares. This total reflects his position following the May 6, 2026 open-market acquisition of 1,000 common shares at a price of $61.6892 per share disclosed in the filing.

Is the GEHC transaction by William J. Stromberg a buy or sell?

The transaction reported by William J. Stromberg is a buy. The Form 4 identifies it as an open-market purchase of 1,000 shares of GE HealthCare Technologies Inc. common stock at $61.6892 per share, increasing his directly owned holdings to 15,330 shares afterward.

Does William J. Stromberg hold GEHC shares directly or indirectly after this transaction?

After the transaction, William J. Stromberg’s 15,330 GE HealthCare Technologies Inc. shares are reported as directly owned. The Form 4 lists the ownership code as “D” for direct, and no trusts, partnerships, or other indirect ownership structures are referenced in the provided data.